Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 77 (2), 393-6

Barrett's Esophagus: The Role of Laparoscopic Fundoplication


Barrett's Esophagus: The Role of Laparoscopic Fundoplication

Abbas E Abbas et al. Ann Thorac Surg.


Background: To review our early operative results and endoscopic findings after laparoscopic fundoplication for Barrett's esophagus (BE).

Methods: From January 1995 through December 2000, 49 patients with BE (35 men and 14 women) underwent laparoscopic antireflux surgery. Median age was 54 years (range, 28 to 85 years). No patient had high-grade dysplasia; 6, however, had low-grade dysplasia. All 49 patients had gastroesophageal reflux symptoms. Heartburn was present in 41 patients (84%), dysphagia in 16 (33%), epigastric or chest pain in 9 (18%), and other symptoms in 16 (33%). A Nissen fundoplication was performed in 48 patients and a partial posterior fundoplication in 1. Forty-one patients (84%) had concomitant hiatal hernia repair.

Results: There were no deaths. Complications occurred in 2 patients (4%). Follow-up was complete in 48 patients (98%) and ranged from 1 to 81 months (median, 29 months). Functional results were classified as excellent in 33 patients (69%), good in 9 (19%), fair in 5 (10%), and poor in 1 (2%). Thirty-three patients (67%) underwent postoperative surveillance esophagoscopy with biopsy. Nine patients (18%) had total regression of BE and 3 (6%) had a decrease in total length. In the 6 patients with preoperative low-grade dysplasia, dysplasia was not found in 4, remained unchanged in 1, and progressed to in situ adenocarcinoma in 1.

Conclusions: Laparoscopic fundoplication is effective in controlling symptoms in the majority of patients with BE. While disappearance of BE may occur in some patients, the possibility of developing esophageal adenocarcinoma is not eliminated by laparoscopic fundoplication. Therefore, endoscopic surveillance should continue.

Similar articles

See all similar articles

Cited by 11 articles

  • Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors.
    Tolone S, Gualtieri G, Savarino E, Frazzoni M, de Bortoli N, Furnari M, Casalino G, Parisi S, Savarino V, Docimo L. Tolone S, et al. World J Gastrointest Surg. 2016 Nov 27;8(11):719-728. doi: 10.4240/wjgs.v8.i11.719. World J Gastrointest Surg. 2016. PMID: 27933133 Free PMC article. Review.
  • Surgical treatments for esophageal cancers.
    Allum WH, Bonavina L, Cassivi SD, Cuesta MA, Dong ZM, Felix VN, Figueredo E, Gatenby PA, Haverkamp L, Ibraev MA, Krasna MJ, Lambert R, Langer R, Lewis MP, Nason KS, Parry K, Preston SR, Ruurda JP, Schaheen LW, Tatum RP, Turkin IN, van der Horst S, van der Peet DL, van der Sluis PC, van Hillegersberg R, Wormald JC, Wu PC, Zonderhuis BM. Allum WH, et al. Ann N Y Acad Sci. 2014 Sep;1325:242-68. doi: 10.1111/nyas.12533. Ann N Y Acad Sci. 2014. PMID: 25266029 Free PMC article.
  • EAES recommendations for the management of gastroesophageal reflux disease.
    Fuchs KH, Babic B, Breithaupt W, Dallemagne B, Fingerhut A, Furnee E, Granderath F, Horvath P, Kardos P, Pointner R, Savarino E, Van Herwaarden-Lindeboom M, Zaninotto G; European Association of Endoscopic Surgery (EAES). Fuchs KH, et al. Surg Endosc. 2014 Jun;28(6):1753-73. doi: 10.1007/s00464-014-3431-z. Epub 2014 May 2. Surg Endosc. 2014. PMID: 24789125
  • Impact of laparoscopic Nissen fundoplication on non-complicated Barrett's esophagus.
    Mohamed AA, Mahran KM, Zaazou MM. Mohamed AA, et al. Saudi J Gastroenterol. 2011 May-Jun;17(3):185-8. doi: 10.4103/1319-3767.80381. Saudi J Gastroenterol. 2011. PMID: 21546721 Free PMC article.
  • Guidelines for surgical treatment of gastroesophageal reflux disease.
    Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD; SAGES Guidelines Committee. Stefanidis D, et al. Surg Endosc. 2010 Nov;24(11):2647-69. doi: 10.1007/s00464-010-1267-8. Epub 2010 Aug 20. Surg Endosc. 2010. PMID: 20725747 Review. No abstract available.
See all "Cited by" articles

MeSH terms